| NCT Number | NCT07521202 |
| Lead Sponsor | Institut fuer Frauengesundheit
Collaborators: Lilly Deutschland GmbH Germany |
| Conditions | HR+/HER2- Early Breast Cancer |
| Enrollment | 257 participants |
| Start Date | 2026-06 |
| Primary Completion | 2029-06 (estimated) |
| Study Completion | 2030-06 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-09 |